Leukocyte telomere length: a novel biomarker to predict the prognosis of glioma patients

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 10, 2015, Pages 1739-1747

  Chen, Yibing ^a   Wu, Yousheng ^a   Huang, Xiaojun ^a   Qu, Ping ^a   Li, Gang ^b   Jin, Tianbo ^c   Xing, Jinliang ^a   He, Shiming ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c NORTHWEST UNIVERSITY   (China)

Author keywords

Cytokine; Glioma; Immunophenotype; Prognosis; Telomere length

Indexed keywords

CYTOKINE; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOPHENOTYPING; LEUKOCYTE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL; TELOMERE HOMEOSTASIS; ADOLESCENT; AGED; CHILD; DISEASE FREE SURVIVAL; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; PROGNOSIS; TELOMERE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CYTOKINES; DISEASE-FREE SURVIVAL; FEMALE; GLIOMA; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PROGNOSIS; TELOMERE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84939566375     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-015-1938-x     Document Type: Article

References (39)

1. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA (2000) Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406(6796):641–645. doi:10.1038/35020592
2. Baydar DE, Ozen H, Geyik PO, Gurel B (2010) Can telomere alterations predict biochemical recurrence in prostate adenocarcinoma? A preliminary study. Pathol Res Pract 206(10):700–704. doi:10.1016/j.prp.2010.05.009
3. Bekaert S, De Meyer T, Van Oostveldt P (2005) Telomere attrition as ageing biomarker. Anticancer Res 25(4):3011–3021
4. Blasco MA (2007) The epigenetic regulation of mammalian telomeres. Nat Rev Genet 8(4):299–309. doi:10.1038/nrg2047
5. Brandsma D, van den Bent MJ (2009) Pseudoprogression and pseudoresponse in the treatment of gliomas. Curr Opin Neurol 22(6):633–638. doi:10.1097/WCO.0b013e328332363e
6. Chen Y, Qu F, He X, Bao G, Liu X, Wan S, Xing J (2014) Short leukocyte telomere length predicts poor prognosis and indicates altered immune functions in colorectal cancer patients. Ann Oncol 25(4):869–876. doi:10.1093/annonc/mdu016
7. Cheung AL, Deng W (2008) Telomere dysfunction, genome instability and cancer. Front Biosci 13(6):2075–2090. doi:10.2741/2825
8. Damjanovic AK, Yang Y, Glaser R, Kiecolt-Glaser JK, Nguyen H, Laskowski B, Zou Y, Beversdorf DQ, Weng NP (2007) Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer’s disease patients. J Immunol 179(6):4249–4254
9. Deelen J, Beekman M, Codd V, Trompet S, Broer L, Hagg S, Fischer K, Thijssen PE, Suchiman HE, Postmus I, Uitterlinden AG, Hofman A, de Craen AJ, Metspalu A, Pedersen NL, van Duijn CM, Jukema JW, Houwing-Duistermaat JJ, Samani NJ, Slagboom PE (2014) Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers. Int J Epidemiol 43(3):878–886. doi:10.1093/ije/dyt267
10. Donson AM, Birks DK, Schittone SA, Kleinschmidt-DeMasters BK, Sun DY, Hemenway MF, Handler MH, Waziri AE, Wang M, Foreman NK (2012) Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors. J Immunol 189(4):1920–1927. doi:10.4049/jimmunol.1103373
11. Feldser DM, Hackett JA, Greider CW (2003) Telomere dysfunction and the initiation of genome instability. Nat Rev Cancer 3(8):623–627. doi:10.1038/nrc1142
12. Fick LJ, Fick GH, Li Z, Cao E, Bao B, Heffelfinger D, Parker HG, Ostrander EA, Riabowol K (2012) Telomere length correlates with life span of dog breeds. Cell Rep 2(6):1530–1536. doi:10.1016/j.celrep.2012.11.021
13. Hou L, Zhang X, Gawron AJ, Liu J (2012) Surrogate tissue telomere length and cancer risk: shorter or longer? Cancer Lett 319(2):130–135. doi:10.1016/j.canlet.2012.01.028
14. La Torre D, Aguennouz M, Conti A, Giusa M, Raffa G, Abbritti RV, Germano A, Angileri FF (2011) Potential clinical role of telomere length in human glioblastoma. Transl Med UniSa 1(1):243-270
15. Liu J, Yang Y, Zhang H, Zhao S, Liu H, Ge N, Yang H, Xing JL, Chen Z (2011) Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a case–control analysis. Cancer 117(18):4247–4256. doi:10.1002/cncr.26015
16. Liu HQ, An JZ, Liu J, Yang YF, Zhang HX, Zhao BY, Li JB, Yang HS, Chen ZN, Xing JL (2012) Leukocyte telomere length predicts overall survival in hepatocellular carcinoma treated with transarterial chemoembolization. Carcinogenesis 33(5):1040–1045. doi:10.1093/carcin/bgs098
17. Lotsch D, Ghanim B, Laaber M, Wurm G, Weis S, Lenz S, Webersinke G, Pichler J, Berger W, Spiegl-Kreinecker S (2013) Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age. Neuro-oncology 15(4):423–432. doi:10.1093/neuonc/nos329
18. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109. doi:10.1007/s00401-007-0243-4
19. Lynch SM, Major JM, Cawthon R, Weinstein SJ, Virtamo J, Lan Q, Rothman N, Albanes D, Stolzenberg-Solomon RZ (2013) A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study. Int J Cancer 133(11):2672–2680. doi:10.1002/ijc.28272
20. Maxwell F, McGlynn LM, Muir HC, Talwar D, Benzeval M, Robertson T, Roxburgh CS, McMillan DC, Horgan PG, Shiels PG (2011) Telomere attrition and decreased fetuin-A levels indicate accelerated biological aging and are implicated in the pathogenesis of colorectal cancer. Clin Cancer Res 17(17):5573–5581. doi:10.1158/1078-0432.CCR-10-3271
21. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY, Ronnett BM, De Marzo AM (2004) Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 10(10):3317–3326. doi:10.1158/1078-0432.CCR-0984-03
22. Mirabello L, Garcia-Closas M, Cawthon R, Lissowska J, Brinton LA, Peplonska B, Sherman ME, Savage SA (2010) Leukocyte telomere length in a population-based case–control study of ovarian cancer: a pilot study. Cancer Causes Control 21(1):77–82. doi:10.1007/s10552-009-9436-6
23. Ohgaki H (2009) Epidemiology of brain tumors. Methods Mol Biol 472:323–342. doi:10.1007/978-1-60327-492-0_14
24. Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS (2014) The epidemiology of glioma in adults: a “state of the science” review. Neuro-oncology. doi:10.1093/neuonc/nou087
25. Qin Q, Sun J, Yin J, Liu L, Chen J, Zhang Y, Li T, Shi Y, Wei S, Nie S (2014) Telomere length in peripheral blood leukocytes is associated with risk of colorectal cancer in Chinese population. PLoS ONE 9(2):e88135. doi:10.1371/journal.pone.0088135
26. Rampazzo E, Bertorelle R, Serra L, Terrin L, Candiotto C, Pucciarelli S, Del Bianco P, Nitti D, De Rossi A (2010) Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers. Br J Cancer 102(8):1300–1305. doi:10.1038/sj.bjc.6605644
27. Raynaud CM, Hernandez J, Llorca FP, Nuciforo P, Mathieu MC, Commo F, Delaloge S, Sabatier L, Andre F, Soria JC (2010) DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer. Am J Clin Oncol 33(4):341–345. doi:10.1097/COC.0b013e3181b0c4c2
28. Seow WJ, Cawthon RM, Purdue MP, Hu W, Gao YT, Huang WY, Weinstein SJ, Ji BT, Virtamo J, Hosgood HD 3rd, Bassig BA, Shu XO, Cai Q, Xiang YB, Min S, Chow WH, Berndt SI, Kim C, Lim U, Albanes D, Caporaso NE, Chanock S, Zheng W, Rothman N, Lan Q (2014) Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. Cancer Res 74(15):4090–4098. doi:10.1158/0008-5472.CAN-14-0459
29. Shirotani Y, Hiyama K, Ishioka S, Inyaku K, Awaya Y, Yonehara S, Yoshida Y, Inai K, Hiyama E, Hasegawa K et al (1994) Alteration in length of telomeric repeats in lung cancer. Lung Cancer 11(1–2):29–41
30. Svenson U, Nordfjall K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, Henriksson R, Lenner P, Roos G (2008) Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res 68(10):3618–3623. doi:10.1158/0008-5472.CAN-07-6497
31. Svenson U, Ljungberg B, Roos G (2009) Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma. Cancer Res 69(7):2896–2901. doi:10.1158/0008-5472.CAN-08-3513
32. Svenson U, Gronlund E, Soderstrom I, Sitaram RT, Ljungberg B, Roos G (2013) Telomere length in relation to immunological parameters in patients with renal cell carcinoma. PLoS ONE 8(2):e55543. doi:10.1371/journal.pone.0055543
33. Valls C, Pinol C, Rene JM, Buenestado J, Vinas J (2011) Telomere length is a prognostic factor for overall survival in colorectal cancer. Colorectal Dis 13(11):1265–1272. doi:10.1111/j.1463-1318.2010.02433.x
34. Vera E, Bernardes de Jesus B, Foronda M, Flores JM, Blasco MA (2012) The rate of increase of short telomeres predicts longevity in mammals. Cell Rep 2(4):732–737. doi:10.1016/j.celrep.2012.08.023
35. Wang S, Chen Y, Qu F, He S, Huang X, Jiang H, Jin T, Wan S, Xing J (2014) Association between leukocyte telomere length and glioma risk: a case–control study. Neuro-oncology 16(4):505–512. doi:10.1093/neuonc/not240
36. Weischer M, Nordestgaard BG, Cawthon RM, Freiberg JJ, Tybjaerg-Hansen A, Bojesen SE (2013) Short telomere length, cancer survival, and cancer risk in 47102 individuals. J Natl Cancer Inst 105(7):459–468. doi:10.1093/jnci/djt016
37. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492–507. doi:10.1056/NEJMra0708126
38. Wilson EH, Weninger W, Hunter CA (2010) Trafficking of immune cells in the central nervous system. J Clin Investig 120(5):1368–1379. doi:10.1172/JCI41911
39. Xu L, Li S, Stohr BA (2013) The role of telomere biology in cancer. Annu Rev Pathol 8:49–78. doi:10.1146/annurev-pathol-020712-164030